Connect with us

Published

on

Lassa Fever Cases On The Rise As Nigeria Enters 41st Week of 2024—-The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a concerning increase in Lassa fever cases as Nigeria navigates epidemiological week 41 of 2024.

In week 41, there were 10 new confirmed cases reported, compared to just seven in the previous week.

The NCDC said this in its latest Lassa Fever Situation Report, published on its official website.

The Public Health agency said that the new cases had been recorded across Ondo, Edo, Benue, and Taraba states, highlighting a worrying trend as the nation grapples with the virus.

Cumulatively, the agency said that there had been 174 reported deaths this year, resulting in a case fatality rate (CFR) of 16.8 per cent.

It said that this was slightly lower than the 17.2 per cent CFR reported during the same period in 2023.

“The total number of confirmed cases has now risen to 8,569 across 28 states and 129 local government areas.

“Notably, 68 per cent of all confirmed Lassa fever cases in 2024 have originated from three states: Ondo 28 per cent, Edo 23 per cent and Bauchi 17 per cent.

“The predominant age group affected is between 31 to 40 years, and there is an equal gender distribution among confirmed cases, with a male-to-female ratio of 1:1.,” it said.

The NCDC, however, said that no new healthcare workers were reported to be affected during week 41, reflecting ongoing efforts to safeguard medical personnel amidst the outbreak.

It said that the National Lassa Fever Multi-Partner, Multi-Sectoral Technical Working Group continued to coordinate response activities, focusing on robust contact tracing and community engagement.

According to the NCDC, the challenges remain, including inadequate funding for preparedness activities and poor health-seeking behaviour in affected communities due to the high costs associated with treatment.

It said that environmental sanitation conditions in high-burden areas also required urgent attention to mitigate the spread of the virus.

“Efforts are underway to improve public awareness and readiness through various initiatives, including risk communication strategies, training sessions for healthcare providers, and ongoing community engagement campaigns,” it said.

As the outbreak continues, stakeholders underlined the importance of timely reporting and seeking medical care to reduce the impact of Lassa fever across the nation.

The News Agency of Nigeria (NAN), reports that Lassa fever has been identified by the World Health Organisation as a pathogen with high potential for severe outbreaks.

It poses a growing threat as climate change puts an estimated 700 million people at risk.

Symptoms of the disease include fever, headache, muscle pain, and in severe cases, facial swelling and bleeding. Survivors often suffer from long-term complications such as deafness.

As Nigeria battles the Lassa fever outbreak, public health experts said that concerted efforts are required from both the government and the general public to avert further loss of lives.

0Shares
Continue Reading
Click to comment

Leave a Reply

News

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India

Published

on

Nipah Virus Cases Emerge in Eastern India

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India—-Sri Lanka has stepped up monitoring measures following reports of a Nipah virus cluster in India’s eastern state of West Bengal.

Health authorities across parts of Asia have also heightened vigilance over the emerging situation, the Daily Mirror reported.

Health officials said Sri Lanka is tracking developments at the regional level and remains in contact with international health monitoring systems.

While no cases have been reported locally, authorities have indicated that preparedness measures are in place should the situation evolve.

The alert follows confirmation by Indian authorities of at least five Nipah virus infections in West Bengal, including cases among healthcare workers.

The development has prompted several countries in the region to strengthen preventive measures, particularly at international airports.

Nipah virus is a zoonotic disease transmitted between animals and humans and, in some instances, through human-to-human contact.

It is classified as a priority pathogen by the World Health Organisation due to its epidemic potential and the severity of illness it can cause. Past outbreaks of the Nipah virus have been associated with high fatality rates, ranging from 40 per cent to 75 per cent. (Xinhua/NAN)

0Shares
Continue Reading

Health & Wellbeing

EL-LAB Limited Marks 2025 World Quality Week With innovation

Published

on

EL-LAB Limited Marks 2025 World Quality Week With innovation

EL-LAB Limited Marks 2025 World Quality Week With innovation

 

EL-LAB Medical Diagnostics and Research Centre, Nigeria’s leading ISO-certified diagnostic centre, today announced its dedication to global quality standards, marking World Quality Week 2025 with the theme “Quality: Think differently” and highlighting its ISO 15189:2022 accreditation.

The centre, which was established in 1998 (27 years ago), has provided advanced medical testing services across Lagos State and continues to contribute significantly to the development of the Nigerian health sector.

Quality: The Silent Foundation of Clinical Decisions

In a statement issued by the company, Mrs. Blessing Nwakobi, Quality Assurance Manager, emphasized that Quality Assurance is the cornerstone of reliable medical diagnosis.

“In healthcare, laboratories are the silent foundation of clinical decisions. Most medical diagnoses rely on accurate laboratory results, thereby making Quality Assurance fundamental to patient safety and clinical excellence,” Mrs. Nwakobi stated

Through the successful transition to the ISO 15189:2022 standard—the highest international benchmark for medical laboratories—EL-LAB demonstrates its unwavering commitment to excellence, impartiality, and safety. This accreditation ensures that the centre’s quality management system is not merely compliant, but a living culture of competence and continual improvement.

The system is strategically built on principles including:

Patient Centred Services
Risk-Based Thinking
Continuous Improvement

·       Staff engagement, Competence and Training

This risk-based approach ensures that all activities which pose a risk to patients are managed proactively, assuring the best possible outcomes across the entire testing process

The robust quality management strategy integrates comprehensive mechanisms to guarantee the integrity of every result. Quality assurance at EL-LAB involves the strict adherence to Standard Operating Procedures (SOPs), vigorous Internal Quality Control (IQC) checks, and mandatory validation via External Quality Assessment (EQA).

These programs ensure that every test result is accurate, reproducible, reliable, and comparable with global benchmarks, reinforcing reliability and building public trust in every report issued by the laboratory.

Addressing the 2025 Quality Week theme, “Quality: Think differently,” EL-LAB’s leadership urged healthcare professionals to challenge traditional quality approaches.

“We believe thinking differently about quality begins with one powerful shift: seeing quality not as an act, but as an attitude”. “Quality is what we do when no one is watching and it shows in how we treat our patients, our colleagues, and our work. The ISO 15189:2022 accreditation is a reminder that quality is not a destination, but a journey of continuous improvement.”

EL-LAB invites all partners, colleagues, and stakeholders in the healthcare ecosystem to join them in thinking differently, noting that the future of diagnostic excellence depends on embracing change today.

About EL-LAB Medical Diagnostics and Research Centre

Established in 1998, EL-LAB Medical Diagnostics and Research Centre is a leading ISO-certified medical laboratory providing advanced, reliable, and comprehensive diagnostic services across Nigeria. Dedicated to clinical excellence and patient safety, EL-LAB leverages state-of-the-art technology and a highly competent workforce to deliver results that form the trusted foundation of patient care.

0Shares
Continue Reading

Trending

0Shares